Anavex Life Sciences Corporation (AVXL)

Jan 10, 2026

Why Anavex Life Sciences Corp. stock could rally in 2025Portfolio Update Report & Free Community Consensus Stock Picks - ulpravda.ru

Jan 10, 2026

Jan 10, 2026

Will Anavex Life Sciences Corp. stock continue upward momentumPortfolio Gains Summary & Technical Pattern Recognition Alerts - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Franklin Credit Management CorporationAVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - FinancialContent

Jan 09, 2026

Jan 09, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp.AVXL - Your Wyoming Link

Jan 09, 2026

Jan 08, 2026

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm - PR Newswire

Jan 08, 2026

Jan 08, 2026

Is Anavex Life Sciences Corp. stock a buy for dividend growth2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Anavex Life Sciences Appoints Wolfgang Liedtke, MD PhD, as Senior Vice President, Global Head of Neurology - Quiver Quantitative

Jan 08, 2026

Jan 08, 2026

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology - Anavex Life Sciences

Jan 08, 2026

Jan 07, 2026

Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's - MSN

Jan 07, 2026

Jan 07, 2026

Anavex Shares Surge on Encouraging Regulatory Development - AD HOC NEWS

Jan 07, 2026

Jan 06, 2026

Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program - Anavex Life Sciences

Jan 06, 2026

Jan 06, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. – AVXL - Chartmill

Jan 06, 2026

Jan 06, 2026

Anavex Life Sciences (AVXL) Receives Reaffirmed Buy Rating from D. Boral Capital | AVXL Stock News - GuruFocus

Jan 06, 2026

Jan 06, 2026

D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat

Jan 06, 2026

Jan 06, 2026

Anavex Life Sciences Corp. Invited by FDA to Present Alzheimer’s Disease Clinical Trial Results - Quiver Quantitative

Jan 06, 2026

Jan 06, 2026

FDA takes closer look at experimental Alzheimer’s pill in key meeting - Stock Titan

Jan 06, 2026

Dec 31, 2025

Analyzing 3 Promising Penny Stocks With Market Caps Over $60M - simplywall.st

Dec 31, 2025

Dec 31, 2025

Anavex Life Sciences (NASDAQ:AVXL) Stock Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

Dec 31, 2025

Dec 24, 2025

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm - GlobeNewswire

Dec 24, 2025

Dec 24, 2025

What analysts say about Anavex Life Sciences Corp stockHigh Beta Stocks & Maximize ROI With Proven Growth Stocks - earlytimes.in

Dec 24, 2025

Dec 22, 2025

Anavex Life Sciences' (AVXL) Buy Rating Reiterated at HC Wainwright - MarketBeat

Dec 22, 2025

Dec 20, 2025

Can Anavex Life Sciences Corp. stock sustain free cash flow growth2025 Price Targets & Daily Volume Surge Trade Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq

Dec 19, 2025

Dec 19, 2025

Can Anavex Life Sciences Corp. stock resist market sell offs2025 Valuation Update & Weekly Watchlist for Consistent Profits - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Rate Cut: Why Anavex Life Sciences Corp stock could be next big winner2025 Trading Volume Trends & Accurate Buy Signal Notifications - moha.gov.vn

Dec 19, 2025

Dec 19, 2025

AVXL Maintains Buy Rating with Price Target Unchanged at $24 by D. Boral Capital | AVXL Stock News - GuruFocus

Dec 19, 2025

Dec 18, 2025

Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's. Read more here. - Seeking Alpha

Dec 18, 2025

Dec 18, 2025

Anavex Life Sciences Requests European Medicines Agency to Re-evaluate Blarcamesine as Early Alzheimer's Treatment - marketscreener.com

Dec 18, 2025

Dec 18, 2025

What catalysts could drive Anavex Life Sciences Corp. stock higher2025 Institutional Moves & Technical Pattern Recognition Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion - The Manila Times

Dec 18, 2025

Dec 18, 2025

Anavex Life Sciences requests EMA to re-examine blarcamesine for Alzheimer's - marketscreener.com

Dec 18, 2025

Dec 18, 2025

EU regulators asked to revisit an experimental pill for early Alzheimer’s - Stock Titan

Dec 18, 2025

Dec 16, 2025

Anavex Life Sciences’ (AVXL) Buy Rating Reaffirmed at D. Boral Capital - Defense World

Dec 16, 2025

Dec 15, 2025

Anavex Life Sciences (AVXL): Analyst Ratings Update for December 15, 2025 | AVXL Stock News - GuruFocus

Dec 15, 2025

Dec 15, 2025

Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from D. Boral Capital - MarketBeat

Dec 15, 2025

Dec 15, 2025

Anavex Life Sciences (AVXL) Projected to Post Quarterly Earnings on Monday - Defense World

Dec 15, 2025

Dec 13, 2025

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease - The Manila Times

Dec 13, 2025